Clinical outcome of High-Risk patients with severe aortic stenosis and reduced left ventricular ejection fraction undergoing medical treatment or TAVI

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Pilgrim, Thomas ^a   Wenaweser, Peter ^a   Meuli, Fabienne ^a   Huber, Christoph ^a   Stortecky, Stefan ^a   Seiler, Christian ^a   Zbinden, Stephan ^a   Meier, Bernhard ^a   Carrel, Thierry ^a   Windecker, Stephan ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; BLEEDING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; REGISTER; SCORING SYSTEM; STROKE; TRANSCATHETER AORTIC VALVE IMPLANTATION; AORTA VALVE STENOSIS; COMPARATIVE STUDY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VALVE REPLACEMENT; MORTALITY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80755176825     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027556     Document Type: Article

References (15)

1. Connolly HM, Oh JK, Orszulak TA, Osborn SL, Roger VL, et al. (1997) Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation 95: 2395-400.
2. Powell DE, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, et al. (2000) Aortic valve replacement in patients with aortic stenosis and severe left ventricular dysfunction. Arch Intern Med 160: 1337-41.
3. Sharony R, Grossi EA, Saunders PC, Schwartz CF, Ciuffo GB, et al. (2003) Aortic valve replacement in patients with impaired ventricular function. Ann Thorac Surg 75: 1808-14.
4. Levy F, Laurent M, Monin JL, Maillet JM, Pasquet A, et al. (2008) Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol 51: 1466-72.
5. Pereira JJ, Lauer MS, Bashir M, Afridi I, Blackstone EH, et al. (2002) Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol 39: 1356-63.
6. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, et al. (2003) A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24: 1231-43.
7. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, et al. (2010) Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med 363 (17): 1597-607.
8. Clavel MA, Webb JG, Rodés-Cabau J, Masson JB, Dumont E, et al. (2010) Comparison between transcatheter and surgical prosthesis valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 122: 1928-1936.
9. Wenaweser P, Pilgrim T, Kadner A, Huber C, Stortecky S, et al. Clinical outcomes of patients with severe aortic stenosis at increased risk according to treatment modality. J Am Coll Cardiol in press.
10. Wenaweser P, Pilgrim T, Roth N, Kadner A, Strotecky S, et al. (2011) Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J 161 (6): 1114-24.
11. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, et al. (2011) Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 57 (3): 253-69.
12. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, et al. (2008) Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving System. Circ Cardiovasc Interv 1: 167-75.
13. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, et al. (2008) Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4: 242-9.
14. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, et al. (2010) Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122 (1): 62-9.
15. Cleveland JC Jr, Shrover AL, Chen AY, Peterson E, Grover FL, (2001) Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. Ann Thorac Surg 72: 1282-9.